Around the World: Australasian Gene and Cell Therapy Society (AGCTS)

(56:13)

ASGCT: The Home of Cell and Gene Therapy

(3:32)

Welcome to ASGCT: Who We Are and What We Do

(2:38)

ASGCT 2022 Presentation Preview

(2:24)

ASGCT 2023 Presentation Overview

(1:35)

ASGCT and HFA Webinar Series Gene Therapy in Bleeding Disorders – Hemophilia

(45:4)

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

(55:21)

What's it Like to Attend the ASGCT Annual Meeting?

(4:7)

Giants of Gene Therapy Podcast 3 - Carl June, MD

(46:20)

Giants of Gene Therapy Podcast 5 - Jennifer Doudna, PhD

(28:28)

cGMP and Building Cohesive Teams with Christopher Choi, PhD, Roswell Park Comprehensive Cancer Ce...

(36:8)

AAV Vector Manufacturing and Analytics

(33:36)

Non-Viral Vector Design and Production

(28:43)

STXBP1 Science + Love = Cure 10 Minute Updates #14

(25:49)

Lunch \u0026 Learn: Intro to Viral Vectors

(1:2:21)

Gene-editing Technologies: Powerful Tools Rewriting the Code of Life

(52:59)

Gene Editing Technologies: Transforming Rare Disease Care

(56:46)

Non-AAV, Non-rare Gene Therapy with Derek Jackson, Pacira BioSciences–The Issue

(44:11)

Welcome to ASGCT: Become a Member

(2:21)

ASGCT 2024 Abstract Highlights with Chris Leidli, Emily Walsh Martin, and Lynnea Olivarez

(45:1econd)

ASGCT 2021 Presidential Symposium: Robert L. Martuza, M.D.

(45:22)

Policy and Advocacy Shorts with Katy Spink, PhD

(31)

Short and Long Read Sequencing for AAV Characterization: BIO-ASGCT CGT Science Series

(57:44)

ASGCT Recap 2023

(4:)

ASGCT \u0026 HFA Webinar Series: Gene Therapy Basics

(53:14)

Gene Therapy Targets and Biomarkers: Molecular Therapy Presents

(1:2:3)

ASGCT 2012 Outstanding New Investigator

(6:54)

An Explosive Year for Gene Therapy with ASGCT President Paula Cannon

(4:40)